These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 3679084

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [HLA and molar pregnancies (triploidies, hydatidiform moles and choriocarcinoma). Etiological and epidemiological study].
    Couillin P, Ravisé N, Afoutou JM, Chaïbi R, Azoulay M, Hors J, Oury JF, Boué J, Boué A.
    Ann Genet; 1987; 30(4):197-208. PubMed ID: 3501264
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A study for the genesis of trophoblastic tumor, with reference to its androgenetic origin].
    Wake N.
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):21-7. PubMed ID: 6325316
    [Abstract] [Full Text] [Related]

  • 5. Human lymphocyte antigen expression in hydatidiform mole: androgenesis following fertilization by a haploid sperm.
    Yamashita K, Wake N, Araki T, Ichinoe K, Makoto K.
    Am J Obstet Gynecol; 1979 Nov 01; 135(5):597-600. PubMed ID: 92196
    [Abstract] [Full Text] [Related]

  • 6. [Pathogenetic study of complete and partial hydatidiform mole by HLA (author's transl)].
    Honda J, Sato E, Ihara S, Munakata S, Sugawara N, Fukushima T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan 01; 34(1):83-8. PubMed ID: 7061896
    [Abstract] [Full Text] [Related]

  • 7. [The propensity to malignancy of dispermic, heterozygous moles].
    Hashimoto M.
    Hokkaido Igaku Zasshi; 1987 Jul 01; 62(4):564-72. PubMed ID: 2960601
    [Abstract] [Full Text] [Related]

  • 8. A study of human leukocyte antigen G expression in hydatidiform moles.
    Goldman-Wohl D, Ariel I, Greenfield C, Hochner-Celnikier D, Lavy Y, Yagel S.
    Am J Obstet Gynecol; 2001 Aug 01; 185(2):476-80. PubMed ID: 11518912
    [Abstract] [Full Text] [Related]

  • 9. [The propensity to malignant changes in heterozygous moles].
    Seki T, Fujita H, Okubo H, Shiina Y, Wake N, Ichinoe K, Kuroda M, Satoh H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec 01; 34(12):2221-8. PubMed ID: 7153599
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Immunobiology of vesicular mole and choriocarcinoma].
    Mangili G, Illeni MT, Spolti N, Lombardo C, Bruno L, Maggi R.
    Ann Ostet Ginecol Med Perinat; 1990 Dec 01; 111(5):326-31. PubMed ID: 2092608
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The propensity to malignancy of dispermic heterozygous moles.
    Wake N, Fujino T, Hoshi S, Shinkai N, Sakai K, Kato H, Hashimoto M, Yasuda T, Yamada H, Ichinoe K.
    Placenta; 1987 Dec 01; 8(3):319-26. PubMed ID: 2821529
    [Abstract] [Full Text] [Related]

  • 18. Hydatidiform mole and HLA. II. Compatibility between patient and conceptus.
    Hansen HE, Vejerslev LO, Larsen SO.
    Tissue Antigens; 1988 Sep 01; 32(3):155-61. PubMed ID: 2851196
    [Abstract] [Full Text] [Related]

  • 19. Chromosome and cellular origin of choriocarcinoma.
    Wake N, Tanaka K, Chapman V, Matsui S, Sandberg AA.
    Cancer Res; 1981 Aug 01; 41(8):3137-43. PubMed ID: 7195772
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.